Publications

Detailed Information

Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma

Cited 3 time in Web of Science Cited 4 time in Scopus
Authors

Kim, Hyojin; Eun, Shin; Jeong, Woo-Jin; Ahn, Soon-Hyun; Bae, Yun Jung; Lee, Joong Seob; Kim, Heejin

Issue Date
2022-08
Publisher
Nature Publishing Group
Citation
Scientific Reports, Vol.12 No.1, p. 13383
Abstract
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignancy that transforms from PA. Early detection of the carcinoma by biopsy is difficult due to similar histopathology of the malignant and benign components. To address this, we investigated and compared the characteristic miRNA expression patterns across samples of the PA, carcinomatous portions (CA) of CXPA, as well as conventional PA. We selected 13 CXPA and 16 conventional PA FFPE samples, separated the PA and CA portions of CXPA samples and conducted miRNA profiling for each group. Among 13 transcripts that were differentially expressed between PA and CA of CXPA, eight miRNAs were up-regulated and five down-regulated in CA. Bioinformatic analysis revealed that the up-regulated miRNAs were related to cancer progression and down-regulated ones to tumor suppression. Additionally, seven miRNAs were significantly up-regulated in PA of CXPA compared to conventional PA, although they are histopathologically similar. Almost all of these transcripts interacted with TP53, a well-known tumor suppressor. In conclusion, we identified differentially expressed miRNAs in PA and CA of CXPA, which were closely associated with TP53 and various cancer-related pathways. We also identified differentially expressed miRNAs in the PA of CXPA and conventional PA which may serve as potential biomarkers.
ISSN
2045-2322
URI
https://hdl.handle.net/10371/185477
DOI
https://doi.org/10.1038/s41598-022-17740-9
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share